About Parnasa Mediworld
Parnasa Mediworld is a Healthcare company. Supply of pharmaceutical medicines in India. The company has 25 employees. Its Indian entity Parnasa Mediworld Private Limited reported revenue of βΉ12.86 Cr. Parnasa Mediworld offers products and services including Bonabond Capsules and CobiMax Capsules. Its focus areas include Pharmaceuticals, Related Products, Powders and Sachets and Medicine Supply.
Company details
Parnasa Mediworld Private Limited is recognized as a supplier of pharmaceutical medicines in the Indian market, with a variety of products such as Bonabond Capsules, CobiMax Capsules, and Collpure Tablets being made available. The company, which was established in 2016 in Delhi, India, operates under the direction of its professionals to ensure that premium lots reach buyers. These medicines are noted for their effectiveness, purity, and hygienic preparation, supporting market needs without promotional emphasis. A group of experts is involved in maintaining quality standards.
- Employees 25
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website parnasamediworld.in
- Social X Facebook
- Legal Name Parnasa Mediworld Private Limited
- Date of Incorporation 17 Mar, 2016
- Jurisdiction New Delhi, Delhi, India
- Indian entity revenue₹12.86 Cr
FY 2025 · +3% YoY
- Indian entity net profit₹17.9 Lakh
FY 2025 · 1% margin
- Indian entity EBITDA₹87.6 Lakh
FY 2025 · 7% margin
- Employee Count25
Associated legal entities of Parnasa Mediworld
Parnasa Mediworld operates through Parnasa Mediworld Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Parnasa Mediworld Private Limited CIN U51397DL2016PTC292781 | Active | 17 Mar 2016 | New Delhi, Delhi | ₹12.9 Cr | 25 | 2 | View details |
Products & Services of Parnasa Mediworld
Parnasa Mediworld offers a comprehensive portfolio of products and services, including Bonabond Capsules and CobiMax Capsules.
Capsules that contain calcium citrate and are utilized for health-related purposes
Capsules that contain Omega-3 and are provided for medicinal applications
Board of directors of Parnasa Mediworld Private Limited (Parnasa Mediworld)
Parnasa Mediworld Private Limited is the primary company behind Parnasa Mediworld. The board of Parnasa Mediworld Private Limited currently have 2 directors; the longest-serving is Keshri Kant Mishra, appointed in 2016. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Keshri Kant Mishra DIN 07471294 | Director | 17 Mar 2016 | 10 yrs 8 mo | Parnasa Mediworld Private Limited |
| Kanak Kant Mishra DIN 07474096 | Director | 17 Mar 2016 | 10 yrs 8 mo | Parnasa Mediworld Private Limited |
Financials of Parnasa Mediworld
Figures of Parnasa Mediworld Private Limited, the primary company behind Parnasa Mediworld, for FY 2025. Revenue was ₹12.86 Cr (+3% year on year). Net profit was ₹17.9 Lakh (1% margin). EBITDA was ₹87.6 Lakh (7% margin). Revenue has grown at a compounded annual rate of +30% over three years and +13% over five years.
- ₹12.86 CrRevenue · FY 2025 · +3% YoY
- ₹17.9 LakhNet profit · 1% margin
- ₹87.6 LakhEBITDA · 7% margin
- ₹5 LakhPaid-up capital
- 25Employees (provident fund records)
- +30%Revenue CAGR, 3 years
- +13%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Parnasa Mediworld Private Limited are on its company page.
Detailed financial statements for Parnasa Mediworld
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Parnasa Mediworld
Parnasa Mediworld has 25 employees.
The primary company behind Parnasa Mediworld, Parnasa Mediworld Private Limited, reported revenue of βΉ12.86 Cr for FY 2025, up 3% year on year.
Parnasa Mediworld Private Limited is recognized as a supplier of pharmaceutical medicines in the Indian market, with a variety of products such as Bonabond Capsules, CobiMax Capsules, and Collpure Tablets being made available. The company, which was established in 2016 in Delhi, India, operates under the direction of its professionals to ensure that premium lots reach buyers. These medicines are noted for their effectiveness, purity, and hygienic preparation, supporting market needs without promotional emphasis. A group of experts is involved in maintaining quality standards.
Parnasa Mediworld offers Bonabond Capsules and CobiMax Capsules.
Parnasa Mediworld operates through Parnasa Mediworld Private Limited.
The legal entities of Parnasa Mediworld currently have 2 directors, including Keshri Kant Mishra, Kanak Kant Mishra.
